Clinical trial
FOCUS:Focus On Coronary Unstable Syndromes
NCT00268619 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00268619 |
|---|---|
| Title | FOCUS:Focus On Coronary Unstable Syndromes |
| Official title | A Placebo-controlled, Double-blind, Randomized, Multicenter Study of Ramipril 5 and 10 mg Capsules and Insulin Infusion in Subjects With Unstable Coronary Syndromes |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Myocardial Ischemia |
| Intervention type | Drug |
| Interventions | Ramipril |
| Start date | Jun 1, 2004 |
| Primary completion | Jul 1, 2005 |
| First posted | Dec 22, 2005 |
| Last update posted | Jan 11, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: